DrGabriele De Rubis

Gabriele holds a Bachelor's Degree in Biotechnology ("La Sapienza" University of Rome, Italy) and a Master's degree in Genetic Sciences and Technologies (University of Sannio, Benevento, Italy). He has just completed a PhD in Pharmacy (thesis under examination) at the Discipline of Pharmacy, Graduate School of Health, UTS, with a thesis on the development of advanced drug delivery systems for respiratory diseases.

Gabriele has experience as an industry-based researcher, particularly in the setup and evaluation of animal (mouse and rat) models of cancer and inflammatory diseases and in the preclinical in vivo testing of the safety, efficacy and pharmacokinetic properties of novel anti-cancer and anti-inflammatory drugs. He also has experience in working under ISO and Good Laboratory Practice (GLP) quality standards and in the setup and coordination of Formulation laboratories for the preparation of experimental drug formulates.

Gabriele's current expertise and research interest cover the in vitro advanced drug delivery of phytoceuticals and nucleic acid-based therapeutics (decoy oligodeoxynucleotides, miRNAs) for the treatment of respiratory inflammatory diseases and lung cancer.